Iovance Biotherapeutics Inc (NASDAQ:IOVA)

Delayed Data
As of Oct 18
 +0.12 / +0.62%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Iovance Biotherapeutics Inc have a median target of 32.00, with a high estimate of 56.00 and a low estimate of 27.00. The median estimate represents a +63.52% increase from the last price of 19.57.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Iovance Biotherapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.80%
Growthannually -17.50%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.